Issue link: https://viewer.e-digitaledition.com/i/1111717
typical children. According to a 2015 study by researchers at Boston Children's Hospital, children with Down syndrome are usually diagnosed at age 8.4 versus 6.5 for typical children. A delayed diagnosis can allow moyamoya disease to progress to a more advanced stage. Dellapina believes an early diagnosis likely would have made a significant difference for her daughter, who, she now believes, showed signs of TIAs as early as age 11. In 2016, Erin underwent pial synangiosis surgery — the typical treatment for moyamoya disease. The procedure involves surgeons creating new blood vessels to supply the brain. It's believed these new blood vessels can do the job better and have a lower risk of bursting than the collaterals. Once the new vessels are functional, patients both with and without Down syndrome enjoy a normal life expectancy, Dr. Steinberg says. "That is why it's so important to diagnose and treat promptly," he says. Unfortunately, strokes and TIAs had already significantly damaged Erin's brain by the time she had surgery, which did not succeed in ending the strokes and seizures. Now 19, she receives hospice care while Dellapina focuses on giving her the best quality of life possible. For 25-year-old Madie Ehlers of Wisconsin, treatment has, so far, been successful. Born with Down syndrome, she was diagnosed with moyamoya disease in late 2013 at age 20. Like Erin, Madie experienced fleeting stroke-like symptoms and was initially misdiagnosed. She has had three surgeries since spring 2014 — two on the left side of her brain and one on the right, and her symptoms have disappeared. Today, Madie is back to being active in her community. She is training to become a certified Zumba instructor and plans to marry her boyfriend next year. "Madie hasn't had any symptoms since two weeks after her most recent surgery in October 2018," says Madie's mother, Mary Beth Freckmann. "Dr. Sacho [who performed the surgery] really believes this will give her a very long life." A POTENTIALLY POTENT PREDICTOR A group of Stanford University researchers suggest that monitoring blood pressure in children with Down syndrome may be an efficient, cost-effective way to identify those at risk of moyamoya disease early. In a study published in October 2018 in the journal Pediatrics, the researchers identified and compared 30 patients with both Down syndrome and moyamoya disease and 116 patients with Down syndrome without the moyamoya disease diagnosis. The study analyzed blood pressure readings taken at 18–24 months, 12–18 months, and 6–12 months before patients' diagnosis with moyamoya disease. When the researchers compared those measurements with ones from the control group taken at the same intervals, they found that blood pressure in children with Down syndrome rose significantly in the two years prior to them receiving a moyamoya disease diagnosis. "We think this finding is very important," says study author Gary Steinberg, M.D., Ph.D., Chair of Neurosurgery, Director of the Stanford Moyamoya Center, and Founder and Co-Director of the Stanford Stroke Center. "Increasing blood pressure may be a very good predictor of who to screen for moyamoya disease." CONTINUED FROM PAGE 11 Mary Beth Freckmann and her daughter, Madie Ehlers GLOBALDOWNSYNDROME.ORG 13

